Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...
SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...
Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first time.
Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 15 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...
A Wall St. street sign is seen near the New York Stock Exchange (NYSE) in New York City, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo The tepid reception to Venture Global's ...
Streaming company Roku (NASDAQ: ROKU) and cosmetics retailer Ulta Beauty (NASDAQ: ULTA) are two stocks with considerable long-term opportunity that are trailing the market's success. Roku has been ...
With a full-blown land war in Ukraine and an isolationist American president back in the White House, European leaders have come to a stark conclusion: They must spend more on their militaries ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Bollywood Hungama is your go-to destination for all things related to Bollywood. Offering a comprehensive range of entertainment news and updates, our site ensures you stay informed about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback